Elly Marcq

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Venues

Cancers

Pharmaceutics

Antioxidants (Basel, Switzerland)

Biomedicines

University of Antwerp

University of Antwerp (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Antwerp Nov 01 2019

Belgium

Post-doctoral researcher Tumor Immunology :: Centre for Oncological Research

University of Antwerp Sep 01 2014 - Oct 31 2019

Belgium

PhD researcher Tumor Immunology :: Centre for Oncological Research

Education History

University of Antwerp Sep 01 2014

Belgium

PHD :: Center for Oncological Research

University of Antwerp Sep 01 2012 - Jun 30 2014

Belgium

MSC :: Biomedical Sciences

University of Antwerp Sep 01 2009 - Jun 30 2012

Belgium

BSC :: Biomedical Sciences

Publications

Laurie Freire Boullosa, Jinthe Van Loenhout, Tal Flieswasser, Christophe Hermans, Céline Merlin, Ho Wa Lau, Elly Marcq, Marlies Verschuuren, Winnok H De Vos, Filip Lardon, Evelien L J Smits, Christophe Deben
Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers. Antioxidants (Basel, Switzerland) 12 (3) (2023)
Laurie Freire Boullosa, Jinthe Van Loenhout, Tal Flieswasser, Christophe Hermans, Céline Merlin, Ho Wa Lau, Elly Marcq, Marlies Verschuuren, Winnok H De Vos, Filip Lardon, Evelien L J Smits, Christophe Deben
Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers. Antioxidants (Basel, Switzerland) 12 (3) (2023)
Laurie Freire Boullosa, Jinthe Van Loenhout, Christophe Hermans, Ho Wa Lau, Céline Merlin, Elly Marcq, Farnaz Sedigheh Takhsha, Wim Martinet, Guido R Y De Meyer, Filip Lardon, Evelien L J Smits, Christophe Deben
Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model. Pharmaceutics 14 (12) (2022)
Yana Debie, Jonas R M Van Audenaerde, Timon Vandamme, Lieselot Croes, Laure-Anne Teuwen, Lise Verbruggen, Greetje Vanhoutte, Elly Marcq, Lisa Verheggen, Debbie Le Blon, Bart Peeters, Maria E Goossens, Pieter Pannus, Kevin K Ariën, Sébastien Anguille, Annelies Janssens, Hans Prenen, Evelien L J Smits, Christof Vulsteke, Eva Lion, Marc Peeters, Peter A van Dam
Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Laurie Freire Boullosa, Jinthe Van Loenhout, Christophe Hermans, Ho Wa Lau, Céline Merlin, Elly Marcq, Farnaz Sedigheh Takhsha, Wim Martinet, Guido R Y De Meyer, Filip Lardon, Evelien L J Smits, Christophe Deben
Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model. Pharmaceutics 14 (12) (2022)
Laurie Freire Boullosa, Jinthe Van Loenhout, Christophe Hermans, Ho Wa Lau, Céline Merlin, Elly Marcq, Farnaz Sedigheh Takhsha, Wim Martinet, Guido R Y De Meyer, Filip Lardon, Evelien L J Smits, Christophe Deben
Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model. Pharmaceutics 14 (12) (2022)
Laurie Freire Boullosa, Jinthe Van Loenhout, Christophe Hermans, Ho Wa Lau, Céline Merlin, Elly Marcq, Farnaz Sedigheh Takhsha, Wim Martinet, Guido R Y De Meyer, Filip Lardon, Evelien L J Smits, Christophe Deben
Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model. Pharmaceutics 14 (12) (2022)
Eline Janssens, Eline Schillebeeckx, Kathleen Zwijsen, Jo Raskin, Joris Van Cleemput, Veerle F Surmont, Kristiaan Nackaerts, Elly Marcq, Jan P van Meerbeeck, Kevin Lamote
External Validation of a Breath-Based Prediction Model for Malignant Pleural Mesothelioma. Cancers 14 (13) (2022)
Sophie Rovers, Annelies Janssens, Jo Raskin, Patrick Pauwels, Jan P van Meerbeeck, Evelien L J Smits, Elly Marcq
Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma. Biomedicines 10 (3) (2022)
Vasiliki Siozopoulou, Andreas Domen, Karen Zwaenepoel, Annelies Van Beeck, Evelien L J Smits, Patrick Pauwels, Elly Marcq
Immune Checkpoint Inhibitory Therapy in Sarcomas: Is There Light at the End of the Tunnel? Cancers 13 (2) (2021)
Elly Marcq, Jonas R M Van Audenaerde, Jorrit De Waele, Céline Merlin, Patrick Pauwels, Jan P van Meerbeeck, Scott A Fisher, Evelien L J Smits
The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3. Cancers 13 (2) (2021)
Vasiliki Siozopoulou, Evelien L J Smits, Koen De Winne, Elly Marcq, Patrick Pauwels
NTRK Fusions in Sarcomas: Diagnostic Challenges and Clinical Aspects. Diagnostics (Basel, Switzerland) 11 (3) (2021)
Jinthe Van Loenhout, Tal Flieswasser, Laurie Freire Boullosa, Jorrit De Waele, Jonas R M Van Audenaerde, Elly Marcq, Julie Jacobs, Abraham Lin, Eva Lion, Heleen Dewitte, Marc Peeters, Sylvia Dewilde, Filip Lardon, Annemie Bogaerts, Christophe Deben, Evelien L J Smits
Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells. Cancers 11 (10) (2019)

Elly Marcq.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Elly Marcq